Literature DB >> 24121302

Synthesis, X-ray structure, interactions with DNA, remarkable in vivo tumor growth suppression and nephroprotective activity of cis-tetrachloro-dipivalato dirhenium(III).

Natalia I Shtemenko1, Helen T Chifotides, Konstantin V Domasevitch, Alexander A Golichenko, Svetlana A Babiy, Zhanyong Li, Katherina V Paramonova, Alexander V Shtemenko, Kim R Dunbar.   

Abstract

In this study we report the synthesis, the X-ray crystal structure and the in vivo tumor growth suppression and nephroprotective activity of bis-dimethylsulfoxide-cis-tetrachlorodi-μ-pivalatodirhenium(III), cis-Re2[(CH3)3CCOO]2Cl4·2(CH3)2SO (I). The interactions of I with DNA were also investigated by electrophoretic mobility shift assays, electronic absorption titrations, ΔTm and viscosity measurements, which indicate that compound I interacts relatively strongly with the DNA (Kb 2.2×10(3)M(-1)), most likely by forming covalent interstrand cross-links, and by kinking and unwinding supercoiled DNA; moreover, DNA cleavage by I is enhanced in the presence of redox-active species. The in vivo antitumor activity of I is considerable and is accompanied by significant elimination of red blood cell and kidney damage. Remarkably, compound I in combination with cisplatin (combined Re-Pt antitumor system) led to suppression of tumor growth or complete tumor elimination. The antihemolytic and nephroprotective abilities of I only or as a part of the Re-Pt antitumor system were established and a possible mechanism for the influence of I on these properties, involving erythropoietin production, is proposed.
© 2013.

Entities:  

Keywords:  Combination therapy; DNA cleavage; Dirhenium; Tumor suppression

Mesh:

Substances:

Year:  2013        PMID: 24121302     DOI: 10.1016/j.jinorgbio.2013.09.001

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  In Vivo Anticancer Activity of a Rhenium(I) Tricarbonyl Complex.

Authors:  Chilaluck C Konkankit; A Paden King; Kevin M Knopf; Teresa L Southard; Justin J Wilson
Journal:  ACS Med Chem Lett       Date:  2019-04-23       Impact factor: 4.345

2.  Crystal structure of cis-bis-(μ-β-alanine-κ(2) O:O')bis[tri-chlorido-rhenium(III)](Re-Re) sesquihydrate.

Authors:  Alexander A Golichenko; Konstantin V Domasevitch; Dina E Kytova; Alexander V Shtemenko
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-01

3.  Confocal fluorescence microscopy studies of a fluorophore-labeled dirhodium compound: visualizing metal-metal bonded molecules in lung cancer (A549) cells.

Authors:  Bruno Peña; Rola Barhoumi; Robert C Burghardt; Claudia Turro; Kim R Dunbar
Journal:  J Am Chem Soc       Date:  2014-05-22       Impact factor: 15.419

4.  Crystal structure of bis-(ethyl-enedi-thio)-tetra-thia-fulvalenium μ2-acetato-bis-[tri-bromido-rhenate(III)] 1,1,2-tri-chloro-ethane hemisolvate.

Authors:  Alexander A Golichenko; Andrey V Kravchenko; Irina V Omelchenko; Denis M Chudak; Vladimir A Starodub; Boleslaw Barszcz; Alexander V Shtemenko
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-04-19

5.  Crystal structure of di-μ-isobutyrato-κ(4) O:O'-bis-[cis-di-chlorido-(dimethyl sulfoxide-κS)rhenium(III)].

Authors:  Alexander A Golichenko; Alexander V Shtemenko
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-09-26

Review 6.  Rhenium-Based Complexes and in Vivo Testing: A Brief History.

Authors:  Miles S Capper; Hollie Packman; Mark Rehkämper
Journal:  Chembiochem       Date:  2020-04-14       Impact factor: 3.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.